PFO
NXTM

Pathstone Family Office’s NxStage Medical Inc. NXTM Stock Holding History

Pathstone Family Office’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-172
Closed -$2K – 297
2014
Q3 		$2K Buy
+172
New +$2.32K 0.01% 297

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pathstone Family Office's NXTM Position: Q4 2014 in Review

Pathstone Family Office sold out of NxStage Medical Inc. (NXTM) in Q4 2014, closing a stake of 172 shares — an estimated $2K sold.

Pathstone Family Office first reported a position in NXTM in Q3 2014 and held it in 1 quarter. The position peaked at $2K in Q3 2014. 118 funds tracked by Wall St. Rank hold NXTM as of Q4 2014.

  • Pathstone Family Office reported no remaining NxStage Medical Inc. position as of Q4 2014 after selling out during the quarter.
  • Pathstone Family Office sold 172 NxStage Medical Inc. shares in Q4 2014, an estimated $2K.
  • Pathstone Family Office first reported a position in NxStage Medical Inc. in Q3 2014 and held it in 1 quarter.
  • Pathstone Family Office's NxStage Medical Inc. position peaked at $2K in Q3 2014.
  • 118 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2014.

Based on Pathstone Family Office's 13F filing for Q4 2014, filed 6 Feb 2015.